Skip to content

ICE: Intracardiac Ultrasound Within the Left Atrium During Radiofrequency Ablation of Nonvalvular Atrial Fibrillation

ICE: Intracardiac Ultrasound Within the Left Atrium During Radiofrequency Ablation of Nonvalvular Atrial Fibrillation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02028143
Acronym
ICE
Enrollment
20
Registered
2014-01-07
Start date
2013-11-30
Completion date
2016-01-31
Last updated
2018-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Atrial Fibrillation

Brief summary

Imaging Real Time within the Left atrial chamber Enhances safety and efficacy of Radiofrequency Ablation of Atrial Fibrillation

Detailed description

Atrial fibrillation is the most common rhythm disturbance affecting the human population. 1. Its prevalence increases with age and can be found in \>8% of humans over the age of eighty; 2. Radiofrequency ablation for drug refractory nonvalvular atrial fibrillation has become a common therapy available to patients. It has been shown to be both efficacious and cost effective; 3. The standard approach to atrial fibrillation involves electrical isolation of the pulmonary veins (PVI) from the rest of the atrium chamber. This involves moving a 3.5mm tip ablation catheter point to point around the PV structures until an encircling ablation line is formed. This can be made difficult by not knowing if the tip is in good contact with the atrial tissue. In addition the esophagus is a posterior lying structure and injury to the esophagus by ablating the overlying tissue has been reported, at times fatal; 4. Currently, intracardiac imaging of the left atrium has FDA approval in the right atrial chamber. This leads to difficulty in visualizing tip tissue interface, and important left sided structures such as carina, ligaments, and esophagus. By placing the tip of the ICE catheter in the left atrium, enhanced visualization of the tip tissue interface may lead to more effective ablation points, fewer needed ablation points, and enhanced safety by avoiding placement over adjacent noncardiac structures.

Interventions

DEVICEBiosense Webster irrigated tip catheter

The second group (study group) will have the ICE catheter placed through one of two existing 8F sheaths already in the left atrium. The ICE catheter will be exchanged in the sheath utilizing the lasso multipolar mapping catheter during left pulmonary vein ablation lines. During exchange, suction and irrigation techniques will be utilized to avoid any air or thrombus embolization. All patients will have standard anticoagulation during the procedure with heparin infusion adjusted to an activated clotting time (ACT) of 350-400. The left sided ICE catheter will be adjusted to visualize left sided structures, ablation tip and tissue interface, and adjacent noncardiac structures such as the esophagus during radiofrequency ablation of the left pulmonary vein system.

PROCEDUREPulmonary vein isolation
PROCEDUREICE catheter placed through one of two existing 8F sheaths

Sponsors

Biosense Webster, Inc.
CollaboratorINDUSTRY
Gregory Jones
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 to 80 years * Recommended for radiofrequency ablation of nonvalvular atrial fibrillation

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
number of lesions requiring ablation to obtain Electrical Isolation PV Systemduring procedureto assess the number of lesions requiring ablation to obtain Electrical Isolation PV system

Secondary

MeasureTime frameDescription
to assess number of lesions to obtain Electrical Isolation PV systemduring procedureEvaluate the time required to obtain electrical isolation of PV system

Other

MeasureTime frameDescription
Safety-Cardiac perforation, emboli, fistula formationduring procedureevaluate the use of ultrasound catheter for adverse events such as cardiac perforation, emboli or fistula formation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026